Partner Content Partner Content SMi’s Exclusive Interview with MedImmune Principal Scientist... An exclusive interview with Dr. Antonio DiGiandomenico, Principal Scientist, MedImmune has been released
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
